Results from the RV172 study
of a vaccine candidate in East Africa conducted by MHRP were published recently in the Journal of Infectious Diseases 2010 Jan 11.
Preclinical
studies of vaccine candidates have typically shown post-infection virologic control, but protection against acquisition of infection has previously only been reported using less rigorous viral challenges.
They have been actively involved in finding immune correlates of protection, implementation of new TB vaccines and
testing of vaccine candidates in murine models.
Importantly, the animals in this model develop broadly neutralising antibodies over successive episodes of placental malaria, as do women, suggesting that this may be an appropriate model for preclinical qualification and down
selection of vaccine candidates.
The Walter Reed Army Institute of Research (WRAIR) began vaccinations today in a Phase 1 clinical trial to evaluate the safety and immune
response of a vaccine candidate to prevent Middle East Respiratory Syndrome (MERS).
The panel discussed progress that's been made including the follow - up to the RV144 Thai prime - boost trial results and in the development of the next
generation of vaccine candidates for testing.
One potential
use of the vaccine candidate Stamatatos is developing would be to combine it with this or other vaccine candidates, adding to the effect of each.
This can inform and accelerate the development of new vaccines, especially important during outbreaks and epidemics when clinical testing
of vaccine candidates need to be fast tracked.
The Pilot Bioproduction Facility headed by Dr. Kenneth H. Eckels, produced small
batches of vaccine candidates that were used for the preclinical studies and is currently manufacturing a vaccine lot for use in initial human clinical studies.
«But the
ability of the vaccine candidate to raise substantial antibodies against the sugar shield in only two months is encouraging; other studies took up to four years to achieve similar results.
Phase IIb trial - A Phase 11b or test - of - concept trial is about finding out if the vaccine concept or the
type of vaccine candidate being tested will be effective.
This has resulted in the
majority of vaccine candidates identified either in rodent models or as the targets of commonly developed antibodies in highly exposed humans.
His approach allows researchers to quickly screen dozens, even hundreds,
of vaccine candidates in the lab and — without having to inject a single person — throw out the ones that don't have a chance of working.
The Walter Reed Army Institute of Research (WRAIR) began vaccinations today in a Phase 1 clinical trial to evaluate the safety and immune
response of a vaccine candidate to prevent Middle East... Read More
That gave us the idea of using a similar approach for the
generation of vaccine candidates for the prevention of CIV, and our initial data using the mouse model of influenza infection support the usefulness of this approach.
Sophie joined EVI in January 2010, and is responsible for overseeing pharmaceutical and subsequent production
of vaccine candidates, as well as ad hoc clinical development.